Navigation Links
Vitamin D Reduces Chances of Colon, Breast And Ovarian Cancers by 50%

Researchers at the Moores Cancer Center at the University of California, San Diego (UCSD) Medical Center report that consuming 1000 International Units (IU) of vitamin D3 // can reduce the risk of developing colon cancer, breast cancer and ovarian cancer.

"For example, breast cancer will strike one in eight American women in their lifetime. Early detection using mammography reduces mortality rates by approximately 20 percent. But use of vitamin D might prevent this cancer in the first place," said study co-author Cedric F. Garland, who is a professor at the Department of Family and Preventive Medicine at the UCSD School of Medicine. The same research team had earlier published a study in the December 2005 Journal of Steroid Biochemistry and Molecular Biology, linking vitamin D deficiency to heightened risk of colon cancer. The researchers say that this deficiency is also found in breast and ovarian cancers.

These conclusions have been arrived at after an exhaustive review of studied on vitamin D and risk of cancer that were conducted between January 1966 and December 2004. A total of 63 studies were assessed among which 30 were of colon cancer, 13 of breast cancer, 26 of prostate cancer and 7 concerned ovarian cancers. "Primary prevention of these cancers has largely been neglected, but we now have proof that the incidence of colon, breast, and ovarian cancer can be reduced dramatically by increasing the public's intake of vitamin D," Professor Garland said. The researchers are calling for concerted public action to see that adequate amounts of Vitamin D are consumed by the population. "We recommend no more than 15 minutes of exposure daily over 40 percent of the body, other than the face, which should be protected from the sun," Garland said. The details of the study appear in the latest online edition of The American Journal of Public Health.

Cedric F. Garland, Edward D. Gorham, Sharif B. Mohr, and Frank C. Garland, affiliated with
'"/>




Page: 1 2

Related medicine news :

1. Vitamin B12 can help in detecting cancers
2. Vitamins-The answer to Heart Disease?
3. Vitamin E, the latest warrior against diabetes
4. Vitamin Shields Brittle Bones
5. B Vitamin protects and lowers toxicity of Arthritis Drug
6. B Vitamin Supplementatoin Saves Money and Lives
7. Eat Vitamin C and stay young
8. Vitamin C for the heart
9. Vitamin B for Hepatitis
10. Vitamins reduce pre-eclampsia
11. Vitamin E useful for Alzheimers

Post Your Comments:
(Date:11/27/2009)... , SAN FRANCISCO, Nov. 27 /PRNewswire-FirstCal...nounced that Blair Lambert, CFO/COO, will present ...l be held at the May Fair Hotel in London, England...T. ,, To listen to a live broadcast of The Gymb... please log on to www.gymboree.com, click on "Our ...
(Date:11/27/2009)... , NEUILLY-SUR-SEINE, France, Nov. 27 /PRNe...can professional cycling team dedicated to ethical...cling champions, announced today that it will beco...ansitions Optical as a new sponsor of the team. Tr...rer of adaptive eyewear, offering the most advance...
(Date:11/27/2009)... XenaCare Holdings has announ...rthritis Foundation, one of the largest nonprofit ...public health education. , ...naCare Holdings, Inc. (OTCBB: XCHO), a company spe... of consumer healthcare products, has announced to...
(Date:11/27/2009)...ing rates to bring unprecedented medical, economic.... 27 (HealthDay News) -- The number of people with...le over the next 25 years, a new study predicts. ,....1 million people with the disease, up from 23.7 m...treating people with diabetes will triple, the stu...
(Date:11/27/2009)... Voyant Health™ announc...gan) has licensed its TraumaCad Enterprise orthope...orkflow solution. , (PRWE...nced today that Spectrum Health (Grand Rapids, Mic...pedic templating solution and its TraumaCad Extend...
Breaking Medicine News(10 mins):Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3
...ards, Find Inspiration in Video Blogs on,Determine...r,couple,s video blogs documenting their efforts t... Pennsylvania Department of Health,s new tobacco,c...to quit smoking together, not just for themselves,...
...eth Campaign to Eliminate Compounded Hormones, WA...mpounding Pharmacists (IACP) today called on the A...AACE) and the North American,Menopause Society (NA...nt. In recent weeks, AACE, NAMS and other supposed...
...dividuals or families may have underlying speech d...ews) -- People with a personal or family history o...rare type of dementia that causes them to lose lan... and progressively impaired, even though the perso...
...ith the recent announcement by,the United States F...ng,safety review of Botox Cosmetic (botulinum toxi...to treat frown lines between the brows. Botox(R),C... In its recent communication, the FDA reports adve...
...Healthcare Services,Inc. (NYSE: AHS ), the nation...oday that Hala Moddelmog, President and Chief Exec...joined the company,s Board of,Directors., "Hala b...ng president and strategic leader of a successful,...
... first PDP to conduct ePrescribing Pilot Study, F...s a bill that would tie physicians, Medicare payme... Health Solutions, Inc. (NYSE: MHS ) today,announ...escriptions. The pilot program will also be used t...
Other Medicine News:Health News:American Association of Clinical Endocrinologists and North American Menopause Society Fail to Disclose Financial Ties to Wyeth Pharmaceuticals 2Health News:Learning Disabilities May Presage Later Language Problems 2Health News:Botox Cosmetic Alternatives Are Available: Surgical Procedures Offer Solution for Wrinkles 2Health News:AMN Healthcare Appoints Hala Moddelmog to Its Board of Directors 2Health News:AMN Healthcare Appoints Hala Moddelmog to Its Board of Directors 3Health News:Medco Launches Medicare Part D Initiative to Promote ePrescribing 2Health News:Medco Launches Medicare Part D Initiative to Promote ePrescribing 3Health News:Medco Launches Medicare Part D Initiative to Promote ePrescribing 4
(Date:11/25/2009)...lif., Nov. 25 ChemoCentryx, Inc....from the Company,s PROTECT-1 (the Prospective Rand...Trial) of Traficet-EN(TM) (CCX282-B) in patients w...d clinical efficacy with a favorable safety and to...ce of clinical efficacy in the reduction of diseas...
(Date:11/24/2009)...Nov. 24 Endologix, Inc. ...treatments for aortic disorders, announced today t...all proceedings in, the patent infringement lawsui... The motion was filed in the United States Distri... has requested that the stay remain in effect whil...
(Date:11/24/2009)...24 Anadys Pharmaceutical...ill present at the 21st Annual Piper Jaffray Healt...:00 a.m. EST (6:00 a.m. PST). The conference is b...land, Ph.D., President and Chief Executive Officer... its clinical development programs, ANA598 and ANA...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Blood Tests May Spot Colon Cancer 58044 1Blood Tests May Spot Colon Cancer 58044 2Blood Tests May Spot Colon Cancer 58044 3Blood Tests May Spot Colon Cancer 58044 4Prix Galien USA to Launch a Health Care Dialogue Among World Leading Innovators in Science Economics and Biotech 58040 1Prix Galien USA to Launch a Health Care Dialogue Among World Leading Innovators in Science Economics and Biotech 58040 2SoluLinK Introduces Product that Links All Biomolecules Greater Than 20 Times Faster with 100 25 Yields 14215 1SoluLinK Introduces Product that Links All Biomolecules Greater Than 20 Times Faster with 100 25 Yields 14215 2
...wing the candidate vaccine induced neutralizing a...ERFIELD, Ill., June 11 Baxter International,Inc. ..., 2008 issue of The,New England Journal of Medicin...avian influenza (H5N1) vaccine, CELVAPAN, met Phas...ty (generating a functional immune,response). This...
...JOLLA, Calif., June 11 Duska Therapeutics,Inc. (O...), announced today,that it has been granted an exc... Johns Hopkins University to develop and commercia...l cardiovascular drugs for the,treatment of heart ...s,expected to enter a Phase II clinical study late...
Other Medicine Technology:The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxter's Cell-Based Pandemic, Avian Flu Vaccine 2The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxter's Cell-Based Pandemic, Avian Flu Vaccine 3The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxter's Cell-Based Pandemic, Avian Flu Vaccine 4The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxter's Cell-Based Pandemic, Avian Flu Vaccine 5Duska Therapeutics Licenses Portfolio of Heart Failure Drugs From Duke and Johns Hopkins 2Duska Therapeutics Licenses Portfolio of Heart Failure Drugs From Duke and Johns Hopkins 3
Siemens Webcast
Siemens Webcast: Legislative Developments Impacting Cardiology Services Reimbursement
...ny pH catheters are designed for patient comfort a...re number marked at 5cm intervals and line marked ...models are available spanning most clinical needs ...e models with one or two sensors., ,Flexilog sing...
...ny pH catheters are designed for patient comfort a...re number marked at 5cm intervals and line marked ...models are available spanning most clinical needs ...e models with one or two sensors., ,A range of fo...
Medicine Products: